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Abstract
Four versions of tricistronic vectors expressing IgG1 light chain (LC), IgG1 heavy chain (HC), and dihydrofolate reductase
(DHFR) in one transcript were designed to compare internal ribosome entry site (IRES) and furin-2A (F2A) for their influence
on monoclonal antibody (mAb) expression level and quality in CHO DG44 cells. LC and HC genes are arranged as either the
first or the second cistron. When using mAb quantification methods based on the detection antibodies against HC Fc
region, F2A-mediated tricistronic vectors appeared to express mAb at higher levels than the IRES-mediated tricistronic
vectors in both transient and stable transfections. Further analysis revealed that more than 40% of products detected in
stably transfected pools generated using the two F2A-mediated tricistronic vectors were aggregates. LC and HC from the
F2A stably transfected pools were not properly processed, giving rise to LC+F2A+HC or HC+F2A+LC fusion proteins, LC and
HC polypeptides with F2A remnants, and incorrectly cleaved signal peptides. Both IRES-mediated tricistronic vectors express
mAb with correct sizes and signal peptide cleavage. Arrangement of LC as the first cistron in the IRES-mediated tricistronic
vectors exhibits increased mAb expression level, better growth, and minimized product aggregation, while arrangement of
HC as first cistron results in low expression, slower growth, and high aggregation. The results obtained will be beneficial for
designing vectors that enhance mAb expression level and quality in mammalian cells.
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Introduction
Monoclonal antibodies (mAbs) are currently the fastest growing
class of biotherapeutic molecules [1,2]. Most mAbs in the market
are immunoglobulin G (IgG) consisting of two identical heavy
chain (HC) and two identical light chain (LC) polypeptides
assembled via disulfide bridges. mAbs are commonly produced by
stable transfection of Chinese hamster ovary (CHO) cells with the
HC, LC and selection marker on either one or two separate
vectors [3–6]. CHO DG44 cells are commonly used due to their
compatibility with dihydrofolate reductase (DHFR), an amplifiable
selection marker. Each gene is under the control of its own
promoter and transcribed separately. One disadvantage of such
designs is that vector fragmentation could result in non-expressing
clones surviving drug selection [7,8]. The other disadvantage is the
lack of control over the ratio of LC:HC expression. LC is required
to facilitate the folding and release of HC from BiP to form a
complete IgG monomer [9]. It has been demonstrated that
expression of LC in excess was beneficial for mAb expression [10–
15]. The ratio of LC:HC expression can also affect mAb qualities
such as aggregation and glycosylation [12,15,16]. Having HC in
excess can cause ER stress [17] and proteasome overloading [18],
creating a burden to the cell machinery and can inhibit cell
proliferation [15].
Tricistronic vectors that express LC, HC, and selection marker
genes in one mRNA are able to alleviate the above problems of
traditional vectors. When vectors get fragmented, the mRNA unit
would be incomplete and no genes would be expressed. Internal
ribosome entry site (IRES) elements, which have a length of
several hundred base pairs, allow expression of multiple genes in
one mRNA. When IRES elements are included between multiple
open reading frames (ORFs), the first ORF is translated by the
canonical cap-dependent mechanism while the rest are translated
through a cap-independent mechanism [19,20]. The IRES-driven
cap-independent translation has lower efficiency than the cap-
dependent translation, resulting in lower expression of IRES-
driven genes [21–23]. A few studies have used IRES for expressing
mAb in mammalian cells [12,24–27]. It has been demonstrated
that an IRES-mediated tricistronic vector expressing LC, HC and
neomycin in one transcript reduced the occurrence of non-
expressing clones and controlled the LC:HC ratios at similar levels
for all clones [12]. Clones generated using this vector expressed
mAb at high levels with low aggregation and consistent
glycosylation [12].
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An alternative approach for co-expressing multiple genes in one
mRNA is using 2A elements. 2A elements are much shorter than
IRES, having only 60 to 80 base pairs. 2A linked genes are
expressed in one single open reading frame and ‘‘self-cleavage’’
occurs co-translationally between the last two amino acids, GP, at
the C-terminus of the 2A polypeptide, giving rise to equal amounts
of co-expressed proteins [28–30]. The exact mechanism involved
is still unclear but it has been suggested to involve a ‘‘ribosomal
skip’’ between the two codons with no peptide bond formation
between G and P [31]. Recent designs have added a furin cleavage
sequence upstream of 2A to eliminate the additional amino acids
which would otherwise remain attached to the upstream protein
after cleavage [32,33]. Furin-2A (F2A) elements have been used
for mAb expression in mammalian cells [32–36] and for in vivo
gene therapy [37]. It has been demonstrated that the productivities
of F2A-vector derived clones were comparable with those derived
from an industry reference vector based on separate expression
unit design [36]. The design of the F2A vector used in that
particular study was not released.
In studies conducted using F2A for mAb expression, mAb
quality has only been characterized by western blotting. Detailed
quality characterization of mAb expressed using F2A has not been
reported. Only one study has compared IRES and F2A for mAb
expression in transient transfections in HEK293 cells [32], in
which the vector with a HC-F2A-LC arrangement gave higher
mAb expression than the vector with a HC-IRES-LC arrange-
ment. It is unclear which element is better when the positions of
HC and LC are reversed. In this work, we sought to identify
whether IRES or F2A works better for expression of humanized
IgG1 in gene amplifiable CHO DG44 cells. We designed four
tricistronic vectors expressing the LC, HC, and dihydrofolate
reductase (DHFR) in one mRNA to compare transient and stable
mAb expression in CHO DG44 cells. The quality of expressed
mAb, including LC and HC polypeptide size, signal peptide
cleavage, and aggregation, was characterized by western blotting,
LC-MS/MS, and size exclusion chromatography (SEC), respec-
tively.
Materials and Methods
Cell Culture and Media
Parental DHFR-deficient CHO DG44 cells (Life Technologies,
Carlsbad, CA) were cultured in suspension using a protein-free
medium consisting of HyQ PF (Hyclone, Logan, UT) and CD
CHO (Life Technologies) at a 1:1 ratio and supplemented with
2 g/L sodium bicarbonate (Sigma-Aldrich, St. Louis, MO), 6 mM
glutamine (Sigma-Aldrich), 0.1% Pluronic F-68 (Life Technolo-
gies), and 1% hypoxanthine and thymine (HT) (Life Technolo-
gies). Regular passaging was carried out every 3 to 4 days in
125 mL shake flasks (Corning, NY) by diluting cells to
26105 cells/mL in 25 mL fresh medium. Cell density and viability
were measured using the trypan blue exclusion method on an
automated Cedex counter (Innovatis, Bielefeld, Germany).
Figure 1. Schematic representation of the four tricistronic vectors for mAb expression. (A) Structure of different vectors. (B) DNA
sequences of the 39 end of IRESwt and IRESatt, amino acid sequences of signal peptide, F2A peptide, N- and C-termini of LC and HC are listed. The
conserved regions of furin cleavage site and 2A peptide are highlighted in dotted boxes. CMV, human cytomegalovirus IE gene promoter; SpA,
simian virus 40 early polyadenylation signal; IRESwt, wild type encephalomyocarditis virus (EMCV) internal ribosomal entry site; IRESatt, mutated
EMCV IRES with attenuated translation efficiency; F2A, furin-2A peptide; LC, light chain cDNA; SPL, LC signal peptide; HC, heavy chain cDNA; SPH, HC
signal peptide; DHFR, dihydrofolate reductase cDNA.
doi:10.1371/journal.pone.0063247.g001
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Vector Construction
Two tricistronic vectors, L-IRES-H and H-IRES-L (Fig. 1),
were obtained by replacing neomycin with DHFR in the
previously described IRES-mediated tricistronic vectors expressing
a biosimilar IgG1 mAb, Herceptin (anti-HER2) [12]. The IRES
used to link the LC and HC genes is a wild-type encephalomyo-
carditis virus (EMCV) IRES (IRESwt). DHFR cDNA was cloned
from the pSV2-DHFR vector (ATCC, Manassas, VA). Another
two tricistronic vectors, L-F2A-H and H-F2A-L, were constructed
by replacing the region of LC-IRESwt-HC with either LC-F2A-
HC or HC-F2A-LC (Fig. 1). F2A, the furin cleavage sequence
linked to the foot-and-mouth disease virus (FMDV) 2A sequence,
was designed based on the literature [33]. The cDNA encoding
F2A was synthesized by 1ST BASE (Singapore). The LC cDNA,
F2A, and HC cDNA were assembled by overlapping PCR. F2A
vectors expressing biosimilar IgG1 Humira (anti-TNFa) and
Avastin (anti-VEGF) were generated by changing the LC and
HC variable regions of the anti-HER2 vectors. The anti-TNFa
Figure 2. Comparison of the four tricistronic vectors for mAb
expression in transient transfections. CHO DG44 cells were co-
transfected with an appropriate mAb expressing vector containing IRES
or F2A between the LC and HC gene and a GFP expressing vector. At
48 h post-transfection, supernatant and cells were collected for analysis
of mAb concentration using ELISA and GFP expression using FACS,
respectively. (A) Measured mAb concentration and GFP mean
fluorescence intensity in each individual transfection. Black bars
represent the mAb concentration and gray bars represent GFP mean
fluorescence intensity. (B) Normalized mAb expression for each vector.
Results represent mAb concentration measured in the culture
supernatant normalized to the internal control, GFP expression to
normalize the transfection efficiency and mAb expression from the L-
IRES-H vector. Each point represents the average and standard
deviation of two measurements from two independant transfections.
doi:10.1371/journal.pone.0063247.g002
Figure 3. Comparison of the four tricistronic vectors for mAb
expression in stable transfections. Stably transfected pools were
generated by transfection of CHO DG44 cells with different tricistronic
vectors containing either IRES or F2A between the LC and HC gene.
Each pool was characterized for (A) specific mAb productivity (qmAb)
measured in pg/cell/day (pcd), (B) growth data collected including
viable cell density (VCD) and culture viability, and (C) titer. Each point
represents the average and standard deviation of two measurements of
two stably transfected pools.
doi:10.1371/journal.pone.0063247.g003
IRES and F2A for Monoclonal Antibody Expression
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and anti-VEGF variable region DNA were synthesized by
Genescript (Piscataway, NJ). All restriction enzymes used were
from New England Biolabs (Ipswich, MA).
Transient Transfections
Transient transfection of DG44 cells were carried out using
Nucleofector kit V and program U-24 on a Nucleofector I system
(Lonza, Cologne, Germany). In each transfection, 26106 cells
were co-transfected with 2 mg of the appropriate mAb encoding
plasmid and 0.2 mg of a green fluorescence protein (GFP)
encoding plasmid pMax-GFP (Lonza). The GFP plasmid acted
as an internal control to account for variations in transfection
efficiency. The transfected cells were then resuspended with 2 mL
of HT-containing protein-free medium in 6-well suspension
culture plates (Greiner Bio-One GmbH, Germany). Transfections
were carried out in duplicates. At 48 h post-transfection, cells and
supernatant were collected to measure GFP fluorescence intensity
using a FACS Calibur (Becton Dickinson, MA) and to measure the
mAb concentration using an enzyme-linked immunosorbent assay
(ELISA) respectively. ELISA was performed as previously
described using capture antibody of affinity purified goat anti-
human IgA+IgG+IgM (HC+LC) (KPL, Gaithersburg, MD) and
detection antibody of goat anti-human IgG (Fc specific) conjugat-
ed to alkaline phosphatase (Sigma-Aldrich) [10].
Stable Transfections
Transfections to generate stably transfected pools were also
performed using Nucleofector Kit V and program U-24 on a
Nucleofector I system (Lonza). 16107 CHO DG44 cells were
transfected with 5 mg of BglII linearized mAb expressing
plasmid. Transfection for each of the four vectors was carried
out in duplicates. The transfected cells were each incubated in
2 mL HT-containing protein-free medium in a 6-well suspen-
sion culture plate for 24 h. Samples were next centrifuged at
,1006g for 5 min and cell pellets resuspended in 15 mL HT-
and protein-free medium in 125 mL shake flasks to select for
stable transfectants. Selection required around 2 to 3 weeks.
When the stably transfected pools recovered with viability above
95%, gene amplification was induced by passaging in medium
containing 50 nM methotrexate (MTX) (Sigma-Aldrich). The
amplification process also required 2 to 3 weeks. Productivity of
stable transfection pools at 50 nM of MTX was determined in
125 mL shake flask batch cultures. Cells were seeded in 25 mL
of medium at a cell density of 26105 cells/mL. Growth was
monitored every day until the end of culture when viability
measurements dropped below 50%. Supernatant was collected
at the end of culture and analyzed for mAb concentration using
a nephelometric method on an IMMAGE 800 immunochem-
istry system (Beckman Coulter, Buckinghamshire, England). The
IMMAGE 800 system utilized anti-human Fc region antibodies
for IgG detection. The specific productivity (qmAb) was
calculated as the mAb concentration divided by the integrated
viable cell density (IVCD) which was determined based on the
trapezoidal method.
Figure 4. Western blot analysis of supernatant in stably
transfected pools generated using the four tricistronic vectors.
Each sample of crude supernatant was analyzed under both (A) non-
reducing and (B) reducing conditions by western blot. A commercial
human affinity purified myeloma Ig1 (Sigma-Aldrich) and supernatants
from cells transfected with either a vector expressing only HC or a
vector expressing only LC were used as positive control, and
supernatant from non-transfected cells as negative control (N). All
blots shown are only from the first replicates generated as duplicates
were observed to exhibit the same product patterns.
doi:10.1371/journal.pone.0063247.g004
Figure 5. SDS-PAGE analysis of purified mAb in stably
transfected pools generated using the four tricistronic vectors.
Protein A purified supernatant was reduced and analyzed on a SDS-
PAGE gel. Protein bands were visualized by coomasie blue staining. All
gels shown are only from the first replicates generated as all duplicates
were observed to exhibit the same product patterns.
doi:10.1371/journal.pone.0063247.g005
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Western Blotting Analysis
Supernatants, which were collected from stably transfected
pools at the end of culture, containing 10 ng of mAb as
determined using the nephelometric method were mixed with
NuPAGE sample loading buffer and reducing buffer (Life
Technologies) and heated at 70uC for 2 min. Samples were
loaded onto NuPAGE 4–12% Bis-Tris gel (Life Technologies) in
MES buffer (Life Technologies). Precision plus protein dual
color standards (Bio-Rad Laboratories, Hercules, CA) were used
as molecular weight ladder and to check for transfer to the
membrane. Proteins were transferred to polyvinylidene difluor-
ide (PVDF) membranes (Life Technologies) using the iBlot
system (Life Technologies). Membranes were blocked in 5%
blocking milk (Bio-Rad Laboratories) in TBS with 0.1% Tween-
20 (Bio-Rad Laboratories) for 1 h at room temperature and
incubated overnight in HRP conjugated goat anti-human IgG
Fc antibody (1:5000; Bethyl Laboratories, Montgomery, TX)
and HRP conjugated goat anti-human IgG Kappa LC
(1:20000; Bethyl Laboratories). Detection was done using ECL
Prime (Amersham-GE Healthcare Life Sciences, Piscataway, NJ)
and exposed on Lumi-Film Chemiluminescent Detection Film
(Roche).
Purification of mAb on Protein A Column
mAb in the supernatant collected at the end of culture of stable
transfection pools was purified by affinity chromatography using
protein A column on a GE AKTA explorer 100 (GE Healthcare,
Uppsala, Sweden) as previously described [12]. This was carried
out for duplicate transfected pools generated using each of the four
tricistronic vectors.
SDS-PAGE Separation of Protein A Purified Sample
Protein A purified mAb in stable transfection pools generated
using different tricistronic vectors were separated by SDS-
PAGE. Prior to SDS-PAGE separation, 10 mg of each purified
mAb sample was denatured by boiling in the presence of 2-
mercaptoethanol (Sigma-Aldrich) at 95uC for 5 min in the
loading buffer containing 0.063 M Tris-HCl at pH of 6.8,
10.5% glycerol (BDH Chemicals, London, England), and 10%
(w/v) SDS (Bio-Rad, Hercules, CA) and 0.1% bromophenol
blue (GE Healthcare), and then ran at 15 mA for 90 min in a
10% T polyacrylamide gel (in-house created). Upon completion,
the gel was immediately fixed and stained in coomassie blue
composed of 0.3% (w/v) Coomassie Brilliant Blue R-250
(Peirce, St. Louis, IL) in 45% methanol and 10% acetic acid,
and then washed with 10% methanol and 5% acetic acid to
remove the background. The gel was scanned on Imagescanner
III (GE Healthcare) and the relative intensities of the protein
bands for each lane were quantified using the ImageQuant TL
7.0 software (GE Healthcare) based on the peak heights of each
generated line graph.
LC-MS/MS Analysis of Protein A Purified mAb
LC-MS/MS analysis was performed on each visible protein
bands observed on the coomasie blue stained SDS-PAGE page
gel. The bands on the gel were excised and washed in 150 mL of
50% acetonitrile (Fisher Scientific, Pittsburgh, PA) solution
containing 25 mM ammonium bicarbonate. The washing solution
was removed and the excised gels were dried using the Savant
Speedvac (Savant Instruments, Holbrook, NY). Proteins within the
excised gels were reduced by adding 25 mL of 20 mM DTT and
incubated at 55uC for 60 min. Upon removal of the reducing
agent, alkylation of the reduced proteins was facilitated by adding
25 mL of 55 mM iodoacetamide (Fluka, Steinheim, Germany) and
incubated at room temperature in the dark for 45 min. The
excised gels were then washed repeatedly in 100 mM ammonium
bicarbonate solution, followed by 100% acetonitrile. After drying
the excised gels using the Savant Speedvac, 20 mL of trypsin
(Promega, Madison, WI) at 0.04 mg/mL in 25 mM ammonium
bicarbonate solution was added to each excised gel sample. The
enzyme-sample mixtures were incubated with agitation at 37uC
overnight. Each digested sample was extracted by adding 20 mL of
acetonitrile with sonication. Each acetonitrile solution containing
digested proteins was transferred to a new clean vial and dried
using the Savant Speedvac. Prior to injecting the samples onto the
LC-MS/MS system, each sample was reconstituted in 5 mL of
aqueous buffer containing 0.1% formic acid (Sigma-Aldrich) and
1% methanol (Fisher Scientific).
LC-MS/MS analyses were performed on a Velos Orbitrap mass
spectrometer (Thermo Fisher Scientific, San Jose, CA) coupled to
a nanoAcquity UPLC system (Waters, Milford, MA) fitted with a
180 mm 6 20 mm Symmetry C18 peptide trap (Waters) and a
75 mm 6 200 mm BEH130 C18 1.7-mm particle size analytical
Table 1. Relative abundance analysis of reduced antibody HC and LC variants by densitometry and sequence identity
confirmation by peptide mapping.
Gel band
Peptide mapping detected
polypeptides L-IRES-H L-IRES-H H-IRES-L H-IRES-L L-F2A-H L-F2A-H H-F2A-L H-F2A-L
























25 LC (214) 87.061.4 47.562.1 87.566.4 44.060.0 ND ND ND ND
25 SPL+LC(236) ND ND ND ND ND ND 79.061.4 39.062.8
30 LC+F2A (242) ND ND ND ND 86.5612.0 37.060.0 ND ND
50 HC (450) 70.560.7 52.562.1 72.060.0 56.060.0 ND ND 71.061.4 32.060.0
50 SPH+HC (469) ND ND ND ND 74.060.0 42.060.0 ND ND
55 SPH+HC+F2A (496) ND ND ND ND ND ND 45.5629.0 12.560.7
80 LC+F2A+SPH+HC (711) ND ND ND ND 67.062.8 21.060.0 ND ND
80 SPH+HC+F2A+SPL+LC (733) ND ND ND ND ND ND 62.564.9 16.562.1
Each point represents the average and standard deviation of two measurements from two stable transfection pools. ‘‘ND’’ means not detected.
doi:10.1371/journal.pone.0063247.t001
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Figure 6. SEC analysis of protein A purified mAb in stably transfected pools generated using the four tricistronic vectors. Species
within protein A purified mAb were separated by SEC followed by the identification and quantification of species by UV detection and light
scattering, respectively. Analysis was done for duplicate stable transfection pools generated using each of the four tricistronic vectors. As results were
consistent, only one typical chromatogram of the first pools analyzed from UV detector for vector (A) L-IRES-H, (B) H-IRES-L, (C) L-F2A-H, (D) H-F2A-L,
are shown. (E) Quantitative comparison of aggregates, complete IgG1 monomers and incomplete IgG1 fragments of four vectors for different species.
Each bar in figure E represents the average and standard deviation of four measurements from two stable transfection pools.
doi:10.1371/journal.pone.0063247.g006
IRES and F2A for Monoclonal Antibody Expression
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column (Waters). Depending on the peptide concentration of each
sample, 1 to 2 mL of peptide digest was injected. Peptides were
resolved by applying a linear binary gradient from 2 to 35%
solvent B at 300 nL/min over 60 min at 35uC, where solvent A
and B were 0.1% (v/v) formic acid in Milli-Q water (Millipore,
Billerica, MA) and 0.1% formic acid in acetonitrile, respectively.
To minimize sample carryover, a dedicated column wash run (10
to 95% B in 30 min) followed by column re-equilibration (2% B
for 30 min) was performed prior to the next sample injection. The
nano-ESI source was fitted with a 30-mm stainless steel nano-bore
emitter (Thermo Fisher Scientific) with 1.7 kV applied near the
tip. The MS instrument method used was the data-dependent
acquisition mode that specified each orbitrap survey scan (at
resolution 60,000) to be linked to a maximum of 10 MS/MS
events; each with maximum ion trap fill time of 25 ms and
isolation window of 2 m/z. The threshold for triggering an MS/
MS was set at 500 counts. The ion trap CID fragmentation
employed an activation time of 10 ms, q value of 0.25 and
normalized collision energy of 35%. Charge state screening was
enabled, with unknown and singly charged states excluded.
Dynamic exclusion was enabled with a list size of 500 and
exclusion time of 60 s.
Acquired LC-MS/MS data were processed by the Proteome
Discoverer 1.3 software (Thermo Fisher Scientific) using the
Sequest search engine. The peptide and fragment ion mass
tolerances used were 65 ppm and 60.5 Da, respectively. The
specified search parameters were carbamidomethylation of cyste-
ine as fixed modification, oxidation of methionine as dynamic
modification and tryptic digestion with 2 missed cleavages.
Depending on the tricistronic vector configuration used (Fig. 1),
each sample LC-MS/MS data was searched against the relevant
full protein sequence to determine the actual expressed protein
sequence for each excised gel band, with its corresponding
sequence coverage calculated.
Aggregation Analysis of Protein A Purified mAb
The aggregation of protein A purified mAb collected at the end
of culture of stable transfection pools was determined using size
exclusion chromatography (SEC) coupled to a UV-visible detector
and a dynamic light scattering detector. Analysis was carried out
for duplicate pools generated using each tricistronic vector. The
instrument setup consisted of a HPLC system (Shimadzu, Kyoto,
Japan) as previously described [12]. Several detectors including
Dawn 8 (light scattering), Optilab (refractive index), and QELS
(dynamic light scattering) were connected in series following a UV-
visible detector. All the three detectors were purchased from Wyatt
Technology Corporation (CA, USA) and were operated by the
ASTRA software. The Chromatography columns used were TSK
Guard column SWXL, 6640 mm and TSK gel G3000 SWXL,
7.86300 mm (Tosoh Corporation, Tokyo, Japan). The hydrody-
namic radius measured by the light scattering detector was used to
calculate the molecular weight of the different compounds present
under each peak. The different fractions were assigned respectively
to aggregates, monomer and fragments based on their measured
molecular weights. The small rightmost peaks are a result of
components in the buffer which the protein A purified samples are
eluted in.
Results
Design of IRES- and F2A-mediated Tricistronic Vectors
An anti-HER2 IgG1 biosimilar was first used as a model mAb
to compare IRES and F2A for mAb expression level and quality.
Four tricistronic vectors were designed to express the anti-HER2
LC, anti-HER2 HC, and DHFR under the control of one CMV
promoter (Fig. 1). LC and HC were arranged in either the first or
the second cistron. The two vectors in which LC and HC are
linked by a wild type EMCV IRES (IRESwt) are designated as L-
IRES-H and H-IRES-L, respectively. Vectors in which LC and
HC are linked by F2A are designated as L-F2A-H and H-F2A-L,
respectively. The DHFR selection marker downstream of an
attenuated EMCV IRES (IRESatt) in the third cistron was used
for all the vectors for fair comparison. Application of IRESatt on
DHFR will reduce its expression and can enhance stringency of
selection for high producers [38]. Tight coupling of product gene
and selection marker in one mRNA can reduce occurrence of non-
expressing clones [12,38,39].
Figure 7. Western blot analysis of transiently expressed anti-
HER2, anti-TNFa and anti-VEGF IgG1 mAbs. CHO DG44 cells were
transfected with an appropriate mAb expressing tricistronic vector
expressing anti-HER2, anti-TNFa, and anti-VEGF. At 48 h post-transfec-
tion, supernatant was collected for western blotting under reducing
condition. The mAb loaded into each lane is identical as determined by
ELISA. A commercial human affinity purified myeloma Ig1 (Sigma-
Aldrich) and supernatants from cells transfected with either a vector
expressing only HC or a vector expressing only LC were used as positive
control, and supernatant from non-transfected cells as negative control
(N). All blots shown are only from the first replicates generated as
duplicates were observed to exhibit the same product patterns.
doi:10.1371/journal.pone.0063247.g007
Figure 8. Estimation of the actual amount of complete IgG1
monomer produced in stably transfected pools generated
using the four tricistronic vectors. The actual monomer amount
was estimated based on the product titers measured by the
nephelometer and the relative monomer peak area observed on SEC
as shown in Figure 6E. Each point represent the average and standard
deviation of two measurements from two stably transfected pools.
doi:10.1371/journal.pone.0063247.g008
IRES and F2A for Monoclonal Antibody Expression
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Comparison of IRES and F2A for mAb Expression Level
IRES and F2A were first compared for transient expression
levels of anti-HER2 in 6-well plate cultures (Fig. 2A and 2B). As
cap-dependent translation of the first cistron is more efficient than
IRES-driven translation, the L-IRES-H vector will express LC in
excess, and the H-IRES-L vector will express HC in excess.
Consistent with previous reports that LC is more favorable for
mAb expression [12,15,26,40], we observed that the mAb
expression level from the L-IRES-H vector to be around double
that from the H-IRES-L vector. A previous study had reported
that mAb expression from a F2A vector similar to H-F2A-L was
greater than that from a EMCV IRES vector similar to H-IRES-L
in transient transfections performed using HEK293 cells [32]. We
observed that both F2A-mediated tricistronic vectors, showed
higher mAb expression levels than those from the IRES-mediated
tricistronic vectors regardless of LC and HC positions. L-F2A-H
had the highest expression with titers at around 500 ng/mL,
threefold higher than the titer of the better performing IRES
vector, L-IRES-H.
Stable anti-HER2 expressions for the four vectors were next
compared using shake flask batch cultures (Fig. 3A). Specific mAb
productivity (qmAb) from the four vectors displayed a similar
trend as that in transient transfections. The qmAb of the L-IRES-
H stable pools was 3.9 pg/cell/day (pcd). The H-IRES-L stably
transfected pools had lower qmAb of 2.7 pcd, which was 70% of
the L-IRES-H stable pools. Both F2A-mediated tricistronic vectors
still exhibited higher qmAb than the IRES-mediated tricistronic
vectors. Compared to L-IRES-H, L-F2A-H qmAb was 1.4-fold
and H-F2A-L was 1.2-fold higher, reaching 5.4 pcd and 4.4 pcd,
respectively.
Stably transfected pools generated using the four vectors also
exhibited differences in growth (Fig. 3B). The L-IRES-H stable
pools grew fastest, followed by pools generated using the L-F2A-H,
H-F2A-L and H-IRES-L vectors. The viability of the former two
pools dropped below 50% at day 10, one day earlier than the latter
two pools. The L-IRES-H stable pools also had highest peak cell
density and IVCD, followed by L-F2A-H, H-F2A-L, and H-IRES-
L. Due to the lower qmAb and even lower IVCD as compared to
L-IRES-H, the H-IRES-L stable pool had 50% lower titer
(Fig. 3C). The lower IVCD of the F2A pools also resulted in titers
of L-F2A-H dropping to 1.1-fold higher than L-IRES-H, and H-
F2A-L dropping lower than L-IRES-H.
Western Blotting Analysis of mAb Products Expressed by
IRES and F2A
Supernatant collected at the end of culture of CHO DG44
stably transfected pools generated using each of the tricistronic
vectors were first analyzed under non-reducing conditions to
characterize the products being secreted (Fig. 4A). Product from
the L-IRES-H vector contained complete IgG1 monomers
HC2LC2, LC2 dimer, and LC monomer, a sign that the L-
IRES-H vector expressed LC in excess. Product from the H-
IRES-L vector consisted of HC2LC2 complete IgG1 and HC2
dimers, providing evidence of expression of excess HC. Products
from both F2A-mediated tricistronic vectors presented a smear
with molecular weight greater than 100 kDa. The fractions above
150 kDa could correspond to mAb aggregates, and those around
150 kDa could be degraded IgG1 monomers, suggesting that mAb
expressed from F2A was not stable. The two thin bands expressed
from the L-F2A-H and H-F2A-L vectors with molecular weights of
100 kDa could be HC2, and the one band from the L-F2A-H
vector with a molecular weight of 80 kDa could be a fusion protein
of LC+F2A+HC.
Figure 9. Hydrophobicity analysis of HC signal peptide
attached with MATT and P amino acid residues at the N-
terminal end. (A) Wild type HC signal peptide (SPH). (B) SPH with MATT
amino acid residues attached to the N-terminal end (MATT+SPH). (C) SPH
with amino acid P attached to the N-terminal end (P+SPH). The 19
amino acids of the HC signal peptide are shown as amino acids 0 to 19.
Additional residues at the N-termini due to IRES and F2A processing are
numbered starting from 21. Kyte-Doolittle index is computed using
Protscale online tool (http://web.expasy.org/cgi-bin/protscale/
protscale.pl).
doi:10.1371/journal.pone.0063247.g009
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Western blotting analysis of reduced products in the supernatant
was next performed to identify the different components in the
IgG1 being produced using the various vectors (Fig. 4B). Two
bands were detected within supernatants from the two IRES-
mediated tricistronic vectors, L-IRES-H and H-IRES-L. Their
molecular weights corresponded to the standard HC and LC,
respectively. Comparing the relative intensities of these two bands
indicated that the L-IRES-H vector expressed LC in excess and
the H-IRES-L vector expressed HC in excess. Interestingly, three
bands were detected in reduced products from the L-F2A-H
vector. The top band presents a molecular weight of approxi-
mately 80 kDa, which is equal to the sum of the molecular weights
of LC, F2A, and HC suggesting that it is a fusion protein of
LC+F2A+HC. The middle band exhibited similar size to the
standard HC. The bottom band had slightly greater size than the
standard LC, indicating a possible failed removal of 2A
polypeptide residue by furin cleavage. Four bands were detected
in products from the H-F2A-L vector. The top two bands could be
the fusion proteins of HC+F2A+LC and HC+F2A based on their
molecular weights. The other two bands had similar sizes to the
standard HC and LC, respectively.
LC-MS/MS Analysis of mAb Products Expressed by IRES
and F2A
IRESwt has three ATGs at the 39 end, which are designated as
ATG-10, ATG-11, and ATG-12 as described previously [41].
ATG-12 is used as the start codon of mAb gene for higher
translation efficiency [42–46]. Translation initiation of EMCV
IRES-driven gene primarily occurs at ATG-11 and partially at
ATG-12 [43]. Four extra amino acid residues, MATT, will be
attached to the signal peptide of the IRES-driven LC or HC in
those polypeptides which translation initiation occurs at ATG-11.
‘‘Self-cleavage’’ of 2A occurs between the last two amino acids,
GP. Following self-cleavage, P will be attached to the signal
peptide of LC or HC downstream of 2A and the rest of the 2A
residues will attach to the C-terminus of the upstream gene.
Addition of a furin cleavage site upstream of 2A can eliminate the
23 amino acid residues which would otherwise be attached to the
HC or LC [32]. When HC is arranged upstream of F2A, design of
a furin cleavage sequence with a second basic amino acid, such as
RRKR, allowed carboxypeptidases to cleave both the RR residues
left after furin cleavage together with the K on the C-terminus of
HC [33].
To characterize the protein more accurately than just using
western blotting, the reduced protein A purified mAb samples
from duplicate pools of each vector were separated on SDS-PAGE
(Fig. 5) and the bands were excised for LC-MS/MS analysis. The
estimated molecular weight of each band, the polypeptide
sequence as determined by peptide mapping and its associated
sequence coverage, and the relative abundance of the expressed
mAb chains are shown in Table 1. The various mAb chains were
determined at high sequence coverage (.65%) with each N- and
C-terminal sequence adequately detected (Figure S1).
The excised gel bands from the L-IRES-H or H-IRES-L vector
at molecular weights of 25 and 50 kDa were confirmed by LC-
MS/MS analyses as LC and HC polypeptides, respectively. The
excised gel bands from the L-F2A-H vector corresponding to
molecular weights of 30, 50, and 80 kDa were LC and F2A fusion
proteins (LC+F2A), HC with incorrect or uncleaved signal peptide
(SPH+HC), and fusion proteins of LC+F2A+SPH+HC, respective-
ly. The four excised gel bands from the H-F2A-L vector with
molecular weights of 25, 50, 55 and 80 kDa were LC with
incorrectly cleaved signal peptide (SPL+LC), HC, SPH+HC+F2A,
and SPH+HC+F2A+SPL+LC, respectively. No incorrect signal
peptide cleavage was observed on LC and HC in the IRES
generated pools. The four extra amino acids which might attach to
the signal peptides during translation initiation at IRES ATG-11
did not seem to affect the signal peptide cleavage. In contrast,
incorrectly cleaved signal peptides were detected in both LC and
HC expressed downstream of F2A as indicated by the detection of
SPL+LC and SPH+HC with signal peptide residues attached. This
is possibly due to attachment of the extra P from F2A to the signal
peptide.
Cleavage of F2A was less efficient in products expressed from
the L-F2A-H vector than the H-F2A-L vector. Occurrence of
LC+F2A+HC or HC+F2A+LC fusion proteins indicates cleavage
failure at both furin and 2A recognition sites. Existence of
LC+F2A or HC+F2A indicates successful cleavage at the 2A
recognition site but cleavage failure at the furin recognition site.
21% of the LC and HC expressed from the L-F2A-H vector
existed as a LC+F2A+SPH+HC fusion protein. The rest were
cleaved into similar abundances of LC+F2A (37%) and SPH+HC
(42%) as expected. 16.5% of product expressed from the H-F2A-L
vector was detected as SPH+HC+F2A+SPL+LC fusion proteins.
The remaining was cleaved into products consisting of 32% HC,
12.5% SPH+HC+F2A, and 39% SPL+LC. The amount of
SPL+LC was similar to the sum of HC and SPH+HC+F2A.
Aggregation Analysis of mAb Products Expressed by IRES
and F2A
Aggregation of protein A purified anti-HER2 IgG1 mAb
produced in stable transfection pools was analyzed and quantified
using SEC coupled to a UV and a dynamic light scattering
detector. As replicate pools gave identical chromatograms, only
one representative UV chromatogram is shown for each vector
(Fig. 6A to 6D). Molecular weight of each peak was calculated
based on their respective hydrodynamic radius. Peaks with average
molecular weight greater than the complete IgG1 monomer were
grouped as aggregates and those with lower molecular weight were
grouped as fragments. Relative mass amounts of aggregates,
monomers and fragments were determined using the respective
peak area under the UV chromatograms. The IgG1 monomer,
aggregate and fragment distributions for each vector design is
shown in figure 6E. The level of aggregates was less than 1% in
products from the L-IRES-H vector. In contrast, products from H-
IRES-L vector had 28% of aggregates and 13% of mAb
fragments. Products from both F2A-mediated vectors had
approximately 45% of aggregates and less than 1% of mAb
fragments. In contrast to multiple aggregate peaks observed in H-
IRES-L (Fig. 6B), F2A-mediated vectors only had one aggregate
peak (Fig. 6C and 6D), suggesting different aggregation mecha-
nisms. Interestingly, aggregates in H-IRES-L did not show up on
western blots performed using the unpurified supernatant while
aggregates in the F2A vectors were visible (Fig. 4A). This is
possibly due to differences in the nature and components of the
aggregates.
Cleavage Efficiency of F2A for Other IgG1 mAbs
Previous reports which utilized F2A for expressing mAb did not
report any issues with 2A peptide cleavage under their tested
conditions [32–34,36] while we observed inefficient F2A cleavage
for anti-HER2 IgG1 expression in CHO DG44 cells. To
investigate whether cleavage efficiency is mAb product dependent,
we expressed two more IgG1 mAbs, anti-TNFa and anti-VEGF,
in transient transfections and checked for cleavage efficiency using
western blotting under reducing conditions (Fig. 7). Bands
corresponding to LC+F2A+HC fusion protein, HC and LC+F2A
fusion protein was observed for reduced anti-HER2 IgG1
IRES and F2A for Monoclonal Antibody Expression
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expressed using the L-F2A-H vector and similar LC+F2A+HC,
HC+F2A, HC and LC bands were observed for H-F2A-L. The
products detected for anti-HER2 in the transient transfections are
similar to that in products from stable transfections from both F2A
vectors as shown earlier in figure 4B. Fusion proteins and
uncleaved F2A residues were also observed for reduced samples
of anti-TNFa and anti-VEGF. Reduced product bands similar to
anti-HER2 were observed for the blots of both L-F2A-H and H-
F2A-L except for an extra smaller band corresponding to LC for
product from the L-F2A-H vectors in addition to the LC+F2A
product band.
Discussion
We designed four tricistronic vectors to compare the use of
EMCV IRES and F2A for IgG1 mAb expression level and quality
in CHO DG44 cells. The mAb quantification methods that we
used in this work, ELISA and nephelometric methods are based
on detection antibodies against the Fc region of the product mAb.
Besides the complete IgG monomer, these assays would detect any
components containing HC, such as high molecular weight
aggregate and HC2 dimer, resulting in falsely high mAb titers.
By measuring mAb in crude supernatant with these two assays,
F2A vectors appeared to give higher mAb expression than IRES
vectors in both transient and stable transfections. However, after
considering the product distribution of complete IgG1 monomers,
aggregates and fragments detected during SEC analysis (Fig. 6E),
the amount of actual IgG1 monomer was significantly lower using
H-IRES-L and the F2A constructs (Fig. 8). Actual titer in L-IRES-
H stable transfection pools was unchanged and the highest at
123 mg/L, while titer of the H-IRES-L, L-F2A-H and H-F2A-L
stable transfection pools dropped to 32 mg/L, 75 mg/L and
60 mg/L respectively.
Arrangement of LC as the first cistron gave higher mAb
expression than arrangement of HC as the first cistron in both
IRES- or F2A-mediated tricistronic vectors. This is understand-
able for the IRES-mediated tricistronic vectors as the L-IRES-H
vector expressed LC in excess (Fig. 4) and extra LC is more
favorable for mAb expression [12,15,26,40]. Both L-F2A-H and
H-F2A-L vectors expressed LC and HC in similar amounts
(Table 1). One possible explanation is LC+F2A from the L-F2A-H
vector can still be processed and does not create any burden to the
cell’s protein folding and assembly machinery while HC+F2A
from the H-F2A-L vector has detrimental effects. Another possible
explanation is that LC+F2A+HC and HC+F2A+LC mRNAs have
different secondary structures, and the former one has higher
translation efficiency and thus yielding higher mAb expression
level.
Secretory proteins like the IgG1 LC and HC are bound by
signal recognition particles (SRP) at their signal peptide sequence
as they emerge from the ribosome within the cytosol and are
targeted to SRP receptors of translocon complex on the ER
membrane for translocation into the ER [47]. Each signal peptide
sequence is separated into three regions: a hydrophilic and net-
positively charged N-terminal region, a central hydrophobic
region and a polar C-terminal region [48]. Studies have shown
that an increase in the hydrophobicity of the N-terminal region
can cause cleavage of the signal peptide to shift upstream [49]. In
our vector designs, four additional amino acid residues, MATT,
would be added to the IRES driven LC or HC peptides and one
additional proline residue would be added for F2A driven
peptides. Hydrophobicity index of the 19 amino acid HC signal
peptide (SPH), HC signal peptide with MATT residues
(MATT+SPH) and HC signal peptide with an additional P
(P+SPH) were analyzed using the Kyte and Doolittle hydropho-
bicity index (Fig. 9) [50]. MATT residues would cause a lower net
change in hydrophobicity of 0.533 as compared to addition of only
one P residue causing a change of 21.067. This larger increased
difference in hydrophobicity due to the P residue from F2A could
be the reason causing incorrect cleavage of the signal peptide.
Another reason for poor signal peptide cleavage could be due to
the F2A reaction being inhibited by interactions between the
nascent protein structure and the translocon complex [51]. SRP
binding to the signal peptide downstream of F2A does not occur
and in turn proper signal peptide cleavage is inhibited. It is also
interesting to note that signal peptide cleavage prediction using
SignalP 4.1 [52] did not indicate any changes to the cleavage site
even with the additional residues.
Incomplete cleavage of F2A had been observed when used with
various fluorescent reporter proteins [51,53]. Previous reports of
using F2A successfully for mAb expression had been in CHOK1
[33,36], CHOK1SV [34] and HEK 293 [32] cells and none of the
reports stated that they were using humanized IgG1 as model
mAb. This is the first report of using the F2A for humanized IgG1
expression in CHO DG44 cells and the possibility of cell and
product specificity affecting cleavage should also not be discount-
ed. All three humanized IgG1 products expressed using the F2A
system in CHO DG44 cells exhibited the presence of incompletely
processed LC and HC products showing that the processing issues
was not specific to only the anti-HER2 mAb that was initially
characterized. While the 2A peptide cleavage was an issue
regardless of product or arrangement, we made some interesting
observations regarding the furin cleavage. Firstly, the different
cistron arrangements affected the furin cleavage efficiency.
Arrangement of LC upstream of F2A inhibited cleavage efficiency
more than arrangement of HC upstream of F2A. This can be seen
from the greater abundance of uncleaved LC+F2A in the L-F2A-
H pools as compared to HC+F2A in the H-F2A-L pools in the
western blot (Fig. 4B). Secondly, furin cleavage appeared to be
dependent on 2A processing as we did not observe fusion proteins
with F2A attached to the N-terminal of the protein translated from
the second cistron, e.g. F2A+HC or F2A+LC. Thirdly, the furin
cleavage efficiency was higher for anti-TNFa and anti-VEGF as
compared to anti-HER2 in the L-F2A-H vectors. It is unclear why
this was observed as the C-terminal ends of the LC attached to the
furin cleavage sequence were the same for all three IgG1 products.
One reason could be due to differences in structure of the
complete IgG1 monomers due to different variable regions. IgGs
are typically fully assembled as HC2LC2 in the ER [54] while furin
endoproteases are mainly localized to the golgi [55]. The
differences in structure of the three products within the golgi
could affect furin cleavage efficiency. Less variation was observed
for furin cleavage of the HC possibly due to the furin cleavage site
being located further away from the differing Fab region.
The L-IRES-H was the best vector design for expressing IgG1
mAb in CHO DG44 cells among the four versions of tricistronic
vectors. While the F2A system is a promising design, issues with
2A processing and furin cleavage affected product yield and
quality. Further optimization of the type of 2A peptide to be used,
addition of GSG linkers and the furin cleavage sequence need to
be performed [33,56]. It would be interesting for another
comparison to be carried out after optimization.
Supporting Information
Figure S1 Peptide mapping of tryptic peptides of LC
and HC expressed from the four tricistronic vectors.
Protein A purified product from duplicated stable transfection
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pools of each vector were analyzed. Purified samples from each
pool were reduced and separated on SDS-PAGE. The bands (refer
Figure 5) were excised for LC-MS/MS analysis. Sequences
highlighted in green denote the tryptic peptides detected by LC-
MS/MS. Underlined amino acid sequences are either signal
peptide or F2A peptide. (A) Sample 1 and 2 produced from H-
F2A-L vector corresponding to excised gel band at 80 kDa. (B)
Sample 1 and 2 produced from H-F2A-L vector corresponding to
excised gel band at 55 kDa band. (C) Sample 1 and 2 produced
from H-F2A-L vector corresponding to excised gel band at
50 kDa band. (D) Sample 1 and 2 produced from H-F2A-L vector
corresponding to excised gel band at 25 kDa band. (E) Sample 1
and 2 produced from L-F2A-H vector corresponding to excised
gel band at 80 kDa band. (F) Sample 1 and 2 produced from L-
F2A-H vector corresponding to excised gel band at 50 kDa band.
(G) Sample 1 and 2 produced from L-F2A-H vector corresponding
to excised gel band at 30 kDa band. (H) Sample 1 and 2 from H-
IRES-L vector corresponding to excised gel band at 50 kDa band.
(I) Sample 1 and 2 produced from H-IRES-L vector correspond-
ing to excised gel band at 25 kDa band. (J) Sample 1 and 2
produced from L-IRES-H vector corresponding to excised gel
band at 50 kDa band. (K) Sample 1 and 2 produced from L-
IRES-H vector corresponding to excised gel band at 25 kDa band.
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